Yarbrough Capital, LLC - REPLIGEN CORP ownership

REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 434 filers reported holding REPLIGEN CORP in Q3 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.1%.

Quarter-by-quarter ownership
Yarbrough Capital, LLC ownership history of REPLIGEN CORP
ValueSharesWeighting
Q3 2023$389,256
+12.4%
2,4480.0%0.02%
+15.0%
Q2 2023$346,294
-16.0%
2,4480.0%0.02%
-41.2%
Q1 2023$412,145
-0.6%
2,4480.0%0.03%
+3.0%
Q4 2022$414,471
-9.5%
2,4480.0%0.03%
-10.8%
Q3 2022$458,000
+15.1%
2,4480.0%0.04%
+23.3%
Q2 2022$398,0002,4480.03%
Other shareholders
REPLIGEN CORP shareholders Q3 2023
NameSharesValueWeighting ↓
12 West Capital Management LP 812,225$215,110,0009.54%
Ally Bridge Group (NY) LLC 70,000$18,539,0006.48%
Miura Global Management 90,000$23,836,0004.04%
LRT Capital Management, LLC 16,710$4,425,0003.37%
AWM Investment Company, Inc. 100,000$26,484,0002.66%
Ranger Investment Management 175,179$46,394,0002.53%
Conestoga Capital Advisors, LLC 653,901$173,179,0002.25%
Spouting Rock Asset Management, LLC 10,679$2,828,0002.22%
Brown Capital Management 1,010,115$267,519,0002.21%
Yorktown Management & Research Co Inc 11,050$2,926,0001.98%
View complete list of REPLIGEN CORP shareholders